AdVTMM2-transduced dendritic cell vaccine
AXP000166.1 · Cancer vaccine
- Platform
- autologous dendritic cells transduced ex vivo with an adenoviral vector
- Originator
- University of Pittsburgh
- Sponsor
- University of Pittsburgh
Names
| Name | Type | Source |
|---|---|---|
| AdVTMM2-transduced dendritic cell vaccine | preferred name | curator |
| AdVTMM2 | code | ncit |
| AdVTMM2-transduced Dendritic Cell Vaccine | synonym | ncit |
Virus
- Role
- Ex vivo gene transfer
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5
- Replication
- non replicating
- Modifications
- non-replicating adenoviral vector encoding tyrosinase, MART-1 and MAGE-A6; used to transduce autologous dendritic cells ex vivo
- Transgenes
- TYR, MLANA, MAGEA6
- Route
- ex vivo
- Carrier
- autologous dendritic cells
- Source
- evidence
Cross-references
- NCI Thesaurus
- C102753
Approvals
No regulatory approval recorded.
Clinical trials (0)
No trial in the latest ClinicalTrials.gov snapshot names this program.
Unconfirmed matches (1)
Trials that mention one of the names in a weaker way (a code only in the title, a short or ambiguous name). Not counted above.
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions | Matched by |
|---|---|---|---|---|---|---|---|---|
| NCT01622933 | Multiple Antigen-Engineered DC Vaccine for Melanoma | Completed | Phase 1 | 2012-06 | 2016-05 | 35 | Melanoma | name in intervention: AdVTMM2 |
Recent changes
No changes recorded in its trials yet.
Clinical papers
No confirmed clinical papers yet.
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 22737604 | Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity. | Oncoimmunology | 2012 | name in abstract: AdVTMM2 |
NIH grants
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| P50CA121973 | Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | BUTTERFIELD, LISA HELENE | 2013–2017 | name in abstract: AdVTMM2-transduced dendritic cell vaccine |
Notes
Autologous dendritic cells transduced outside the body with an adenovirus encoding tyrosinase, MART-1 and MAGE-A6 (AdVTMM2), then given back to the patient; phase 1 in melanoma. Entered as ex vivo gene transfer: the adenovirus modifies the cells rather than being administered itself.
How to cite
AdVTMM2-transduced dendritic cell vaccine (AXP000166.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000166.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.